Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Kantum Pharma was founded based on pioneering work from the laboratory of our scientific founder, Dr. Sylvie Breton, at MGH/Harvard Medical School. The Company is focused on translating her important research on the UDP-glucose/P2Y14 receptor signaling pathway into potentially transformative therapies in order to improve outcomes and patients’ lives. The company’s lead program, KB-1801, is based on technology licensed...
Kantum Pharma was founded based on pioneering work from the laboratory of our scientific founder, Dr. Sylvie Breton, at MGH/Harvard Medical School. The Company is focused on translating her important research on the UDP-glucose/P2Y14 receptor signaling pathway into potentially transformative therapies in order to improve outcomes and patients’ lives. The company’s lead program, KB-1801, is based on technology licensed from MGH and is currently in preclinical development for prevention of acute kidney injury.

List your booth number for exhibitions, ask us